Today's pre-market stock movers: IGMS, NLSN, NEO and more

• $The Lovesac(LOVE.US)$ +16.39%, $Ginkgo Bioworks(DNA.US)$ +10.16%, $Jefferies Financial(JEF.US)$ +4.3%, $Taboola Com(TBLA.US)$ +5.05%

• $IGM Biosciences(IGMS.US)$ +36.02% (IGM Biosciences and Sanofi announce collaboration agreement for oncology immunology and inflammation targets; also reported earnings)

• $Nielsen(NLSN.US)$ +21.79% (enters into agreement to be acquired by Evergreen and Brookfield (BBU) consortium for $16 bln)

• $Vertical Aerospace(EVTL.US)$ +13.3% (Avolon exceeds pre-order commitments)

• $LHC Group(LHCG.US)$ +7.3% (LHC Group and Optum have agreed to combine to further strengthen their shared ability to advance valuebased care especially in the comfort of a patient's own home)

• $Lucira Health(LHDX.US)$ +5.5% (Lucira Health COVID-19 & flu at-home molecular test shows positive clinical study results)

• $Berkshire Hills Bancorp(BHLB.US)$ +4.9% (expands partnership with FinTech firm Narmi to enhance its digital banking experience)

• $Taysha Gene Therapies(TSHA.US)$ +4.3% (announces the initiation of clinical development of TSHA-102 for the treatment of Rett syndrome under a recently approved Clinical Trial Application by Health Canada)

• $Novo-Nordisk A/S(NVO.US)$ +3.1% (FDA approves 2.0 mg dose of Ozempic)

• $Barclays(BCS.US)$ +2.8% (provides impact of over-issuance under BBPLC US shelf; Barclays expects the rescission losses (net of tax) to be GBP 450 mln)

• $Scorpio Tankers(STNG.US)$ +2.5% (enters into Moll with Carbon Ridge to develop onboard carbon capture)

• $Hoegh LNG(HMLP.US)$ +3.5% (upgraded to Buy from Hold at Stifel)

• $Fortinet(FTNT.US)$ +2.6% (upgraded to Overweight from Equal Weight at Barclays)

• $Customers Bancorp(CUBI.US)$ +1.9% (upgraded to Outperform from Mkt Perform at Keefe Bruyette)

• $Aveanna Healthcare(AVAH.US)$ -16.51%, $Lightning eMotors(ZEV.US)$ -11.48%, $Conn's(CONN.US)$ -11.91%, $Dave & Buster's Entertainment(PLAY.US)$ -5.4%, $AEye(LIDR.US)$ -11.43%

• $NeoGenomics(NEO.US)$ -29.45% (CEO steps down, co lowers QI revenue and EBITDA guidance)

• $Lipocine(LPCN.US)$ -19.23% (FDA approves Antares Pharma's (ATRS) TLANDO (testosterone undecanoate) oral treatment for testosterone replacement therapy; commercial launch expected in 2Q 2022)

• $Neurocrine Biosciences(NBIX.US)$ -3.8% (collaboration partner receives regulatory approval for Dysval in Japan)

• $Southwest Gas Holdings(SWX.US)$ -3.5% (prices offering of 5.5 mln shares of common stock at $74,00 per share)

• $TheRealReal(REAL.US)$ -4.1% (downgraded to Neutral from Outperform at Credit Suisse)

• $Bright Health Group(BHG.US)$ -4% (downgraded to Neutral from Overweight at JP Morgan)

• $Pinterest(PINS.US)$ -2.7% (downgraded to Equal-Weight from Overweight at Morgan Stanley)

• $Etsy Inc(ETSY.US)$ -1.9% (downgraded to Hold from Buy at Loop Capital)

• $CVS Health(CVS.US)$ -1.5% (downgraded to Hold from Buy at Deutsche Bank)